Gene cloning and genetic engineering: Applications in disease treatment and prevention

Abstract

Gene cloning and genetic engineering have revolutionized molecular biology, leading to major advancements in genetic disease treatment and prevention. Gene cloning enables the replication of specific genes for therapeutic purposes, facilitating the isolation of genes of interest. Genetic engineering involves manipulating DNA to produce desired traits or therapeutic proteins. These technologies have given rise to innovative strategies such as gene therapy, recombinant protein production, and the creation of genetically modified organisms (GMOs) with enhanced disease resistance. In disease treatment, gene cloning and genetic engineering have led to the development of targeted therapies. These include genetically modified viruses used to deliver therapeutic genes to patients, which can correct defective genes linked to disorders like cystic fibrosis, muscular dystrophy, and certain cancers. Additionally, recombinant proteins such as insulin, growth factors, and monoclonal antibodies have transformed disease treatment. Genetic engineering has also significantly advanced disease prevention. Genetically modified crops resistant to pests and diseases enhance food security, and vaccines produced from genetically engineered organisms, like the hepatitis B vaccine, have been effective in preventing viral infections. Despite their potential, ethical concerns regarding gene editing and unforeseen consequences remain important considerations.